Striped Bass Ovarian Transcriptome Sequence Contigs

 Records 801 - 900:
Sequence Name Description Length Blast Hits min E-value Similarity GO hits GO names Enzyme Codes InterPro Scan
contig00801 alpha- muscle-specific form gp220 1671 20 3.49E-83 82.60% 7 C:cytoplasm; F:transcription coactivator activity; F:DNA binding; F:TATA-binding protein binding; C:nucleus; P:regulation of transcription, DNA-dependent; P:protein transport    
contig00802 chromobox homolog 8 (pc class drosophila) 897 20 3.73E-84 75.10% 8 C:PcG protein complex; P:histone ubiquitination; P:chromatin silencing; F:ubiquitin-protein ligase activity; C:chromatin; F:protein binding; C:ubiquitin ligase complex; F:chromatin binding EC:6.3.2.19  
contig00803 ---NA--- 350 0     0      
contig00804 ribosomal protein l10 831 20 1.36E-122 96.60% 6 P:spermatogenesis; F:structural constituent of ribosome; C:large ribosomal subunit; C:nucleus; P:translation; C:endoplasmic reticulum EC:3.6.5.3  
contig00805 set and mynd domain containing 3 627 20 2.87E-61 64.00% 1 F:protein binding    
contig00806 ---NA--- 675 0     0      
contig00807 ---NA--- 772 0     0      
contig00808 ---NA--- 569 0     0      
contig00809 nadh dehydrogenase 1 alpha 42kda 1267 20 2.43E-152 77.70% 7 F:binding; F:NADH dehydrogenase (ubiquinone) activity; C:mitochondrial respiratory chain complex I; P:ubiquinone biosynthetic process; F:phosphotransferase activity, alcohol group as acceptor; P:mitochondrial electron transport, NADH to ubiquinone; P:nucleobase, nucleoside, nucleotide and nucleic acid metabolic process EC:1.6.5.3; EC:2.7.1.0  
contig00810 mgc86401 protein 693 20 7.99E-21 55.95% 3 P:triglyceride catabolic process; F:triglyceride lipase activity; C:cytosol EC:3.1.1.3  
contig00811 programmed cell death 8 (apoptosis-inducing factor) 1819 11 8.47E-30 63.36% 3 P:cell redox homeostasis; F:oxidoreductase activity; F:FAD binding    
contig00812 ---NA--- 291 0     0      
contig00813 ---NA--- 488 0     0      
contig00814 glyceraldehyde-3-phosphate dehydrogenase 248 20 1.22E-28 95.90% 4 C:cytoplasm; F:NAD or NADH binding; P:glycolysis; F:glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity EC:1.2.1.12  
contig00815 microfibrillar-associated protein 1 1012 20 3.85E-83 94.20% 2 F:extracellular matrix structural constituent; C:proteinaceous extracellular matrix    
contig00816 cleavage and polyadenylation specificity factor isoform cra_b 291 20 3.15E-48 100.00% 5 P:mRNA polyadenylation; F:endonuclease activity; C:mRNA cleavage and polyadenylation specificity factor complex; F:mRNA binding; F:zinc ion binding    
contig00817 guanine nucleotide binding 3 462 20 4.30E-29 73.95% 2 C:nucleolus; F:nucleotide binding    
contig00818 ---NA--- 255 0     0      
contig00819 ectodysplasin [Gasterosteus aculeatus] 334 2 1.15E-26 81.00% 5 P:immune response; C:membrane; C:cytoplasm; F:tumor necrosis factor receptor binding; P:phosphate transport    
contig00820 kinesin family member 22 1769 20 0 68.55% 6 C:chromatin; C:microtubule associated complex; F:DNA binding; C:spindle; P:microtubule-based process; F:motor activity    
contig00821 gtp binding protein 5 604 20 6.21E-71 80.75% 3 C:mitochondrion; P:ribosome biogenesis; F:GTP binding    
contig00822 egg membrane protein 1390 20 2.21E-117 58.90% 2 C:chorion; C:viral envelope    
contig00823 member ras oncogene family 1064 20 9.21E-83 88.50% 7 P:protein amino acid phosphorylation; F:GTP binding; F:protein kinase activity; F:ATP binding; P:small GTPase mediated signal transduction; C:mitochondrion; P:protein transport    
contig00824 eorge syndrome critical region gene 8 328 20 2.25E-38 80.15% 5 C:cytoplasm; F:double-stranded RNA binding; P:primary microRNA processing; F:protein binding; C:nucleus    
contig00825 leydig cell tumor 10 kda protein 428 7 2.77E-12 81.00% 2 P:P; C:C    
contig00826 calcium voltage- alpha 1f subunit 505 20 4.00E-09 62.95% 6 F:calcium channel activity; C:protein complex; C:plasma membrane part; F:voltage-gated cation channel activity; C:integral to membrane; P:metal ion transport    
contig00827 nadh dehydrogenase subunit 1 993 20 1.41E-98 91.50% 4 C:integral to membrane; C:mitochondrion; F:NADH dehydrogenase (ubiquinone) activity; P:electron transport EC:1.6.5.3  
contig00828 proteasome ( macropain) assembly chaperone 2 1154 20 5.13E-98 73.75% 3 C:nucleus; P:proteasome assembly; F:protein binding    
contig00829 cell death-inducing dffa-like effector c 1068 20 3.54E-74 73.90% 2 C:cytosol; P:induction of apoptosis    
contig00830 nop16 nucleolar protein homolog 995 20 3.08E-61 70.30% 1 C:nucleus    
contig00831 ---NA--- 277 0     0      
contig00832 dihydrouridine synthase 2- smm1 homolog ( cerevisiae) 499 20 1.42E-67 83.20% 5 F:double-stranded RNA binding; F:FAD binding; C:endoplasmic reticulum; F:tRNA dihydrouridine synthase activity; P:tRNA processing    
contig00833 pyruvate muscle 281 20 5.65E-34 86.15% 4 F:pyruvate kinase activity; F:potassium ion binding; F:magnesium ion binding; P:glycolysis EC:2.7.1.40  
contig00834 rrm1 protein 309 20 3.65E-49 96.10% 5 C:ribonucleoside-diphosphate reductase complex; P:DNA replication; F:protein binding; F:ATP binding; F:ribonucleoside-diphosphate reductase activity EC:1.17.4.1  
contig00835 ---NA--- 491 0     0      
contig00836 regulator of chromosome condensation 2 429 20 1.61E-69 72.70% 2 P:cellular process; C:intracellular organelle    
contig00837 ---NA--- 273 0     0      
contig00838 synaptic 2 577 20 1.61E-53 93.65% 4 C:endoplasmic reticulum membrane; P:steroid biosynthetic process; F:oxidoreductase activity, acting on the CH-CH group of donors; C:integral to membrane    
contig00839 cornichon homolog 1133 20 3.05E-63 94.75% 6 C:Golgi membrane; C:endoplasmic reticulum membrane; ; P:vesicle-mediated transport; C:integral to membrane; P:immune response    
contig00840 ribosomal protein l22 446 20 8.30E-49 95.65% 6 F:heparin binding; P:ribosome biogenesis; F:structural constituent of ribosome; F:RNA binding; C:cytosolic large ribosomal subunit; P:translation EC:3.6.5.3  
contig00841 nucleoporin 160kda 605 20 4.34E-40 75.85% 6 C:nuclear pore; F:acid phosphatase activity; P:mRNA export from nucleus; F:nucleocytoplasmic transporter activity; F:protein binding; P:protein transport EC:3.1.3.2  
contig00842 jun b proto-oncogene 297 20 4.70E-28 74.40% 7 F:sequence-specific DNA binding; P:response to cadmium ion; F:protein dimerization activity; F:transcription factor activity; C:nucleus; P:response to methylmercury; P:regulation of transcription, DNA-dependent    
contig00843 ---NA--- 1270 0     0      
contig00844 ---NA--- 799 0     0      
contig00845 proteolipid protein 1b 859 20 5.92E-84 73.90% 1 C:integral to membrane    
contig00846 mannose- 1 657 20 3.93E-11 88.70% 11 P:protein folding; C:integral to membrane; C:Golgi membrane; F:mannose binding; C:ER-Golgi intermediate compartment membrane; P:ER to Golgi vesicle-mediated transport; F:unfolded protein binding; C:endoplasmic reticulum membrane; P:protein transport; P:blood coagulation; C:sarcomere    
contig00847 growth differentiation factor 3 1277 20 1.82E-155 64.50% 10 F:morphogen activity; P:determination of left/right symmetry; P:mesoderm formation; F:receptor binding; P:cellular process; P:anterior/posterior pattern formation; C:extracellular region; F:protein heterodimerization activity; F:growth factor binding; F:protein homodimerization activity    
contig00848 ribosomal protein s10 550 20 2.19E-71 95.70% 5 F:structural constituent of ribosome; F:RNA binding; F:protein binding; C:cytosolic small ribosomal subunit; P:translation EC:3.6.5.3  
contig00849 double-stranded rna activated protein kinase 1078 20 3.25E-75 62.70% 2 F:left-handed Z-DNA binding; F:kinase activity    
contig00850 ---NA--- 501 0     0      
contig00851 ---NA--- 259 0     0      
contig00852 zinc finger protein c3h type-like 2 1170 20 2.54E-76 58.10% 5 C:cytoplasm; P:regulation of mRNA stability; F:nucleic acid binding; C:nucleus; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay    
contig00853 novel protein 2983 20 5.65E-101 54.40% 3 F:binding; P:P; C:C    
contig00854 adenosine trna-specific 1 274 20 1.50E-24 73.75% 4 F:metal ion binding; F:RNA binding; F:tRNA-specific adenosine deaminase activity; P:tRNA processing    
contig00855 mical-like 2 353 20 8.32E-25 73.20% 5 F:metal ion binding; C:tight junction; ; F:protein binding; P:endocytosis    
contig00856 ---NA--- 254 0     0      
contig00857 chromosome 14 open reading frame isoform cra_a 896 20 6.00E-34 67.95% 2 F:F; C:C    
contig00858 raly rna binding isoform 2 317 20 1.14E-21 83.15% 2 F:nucleotide binding; F:RNA binding    
contig00859 wd repeat domain 74 569 20 3.79E-69 67.80% 3 P:P; C:nucleus; C:C    
contig00860 class type member 1 354 20 4.98E-54 94.20% 12 P:bile acid and bile salt transport; C:brush border membrane; F:ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; C:membrane fraction; F:ATP binding; P:phospholipid transport; P:bile acid metabolic process; F:magnesium ion binding; C:apical plasma membrane; F:phospholipid-translocating ATPase activity; P:negative regulation of transcription; C:integral to plasma membrane EC:3.6.3.1  
contig00861 eukaryotic translation initiation factor subunit 6 interacting protein 1099 20 2.37E-159 98.00% 4 C:fibrillar center; C:nucleoplasm; F:protein binding; P:translation EC:3.6.5.3  
contig00862 dna methyltransferase 1 associated protein 1 818 20 4.02E-108 81.65% 10 P:chromatin modification; P:regulation of cell growth; F:DNA binding; F:transcription corepressor activity; C:replication fork; P:retina development in camera-type eye; P:negative regulation of transcription, DNA-dependent; P:DNA methylation; F:methyltransferase activity; C:nucleus EC:2.1.1.0  
contig00863 ---NA--- 530 0     0      
contig00864 ---NA--- 270 0     0      
contig00865 ---NA--- 267 0     0      
contig00866 ribosomal protein l37a 439 20 4.45E-47 97.25% 6 C:cytosolic ribosome; P:ribosome biogenesis; F:structural constituent of ribosome; F:protein binding; F:zinc ion binding; P:translation EC:3.6.5.3  
contig00867 rna binding motif protein 34 1582 20 6.13E-66 75.90% 1 F:nucleic acid binding    
contig00868 heat shock protein 1 1001 20 1.46E-18 99.35% 26 C:membrane raft; P:response to lipopolysaccharide; F:chaperone binding; P:protein folding; P:response to hydrogen peroxide; F:insulin binding; C:mitochondrial matrix; P:response to ATP; C:secretory granule; C:mitochondrial inner membrane; P:response to estrogen stimulus; C:Golgi apparatus; P:fin regeneration; P:positive regulation of anti-apoptosis; C:cytosol; F:protein heterodimerization activity; P:response to hypoxia; F:unfolded protein binding; P:response to drug; F:protease binding; P:response to heat; P:positive regulation of inflammatory response; C:cyclin-dependent protein kinase activating kinase holoenzyme complex; C:rough endoplasmic reticulum; F:ATP binding; P:response to cocaine    
contig00869 ---NA--- 254 0     0      
contig00870 ---NA--- 433 0     0      
contig00871 coiled-coil domain containing 25 954 20 2.20E-53 90.55% 2 F:F; C:C    
contig00872 ---NA--- 1262 0     0      
contig00873 novel protein vertebrate yip1 interacting factor homolog b ( cerevisiae) ( zgc:103562) 715 20 4.61E-83 83.20% 1 C:integral to membrane    
contig00874 hbv 1-transactivated protein 3 622 20 1.94E-38 73.25% 2 P:P; C:C    
contig00875 ---NA--- 142 0     0      
contig00876 kinetochore associated 2 2335 20 0 67.20% 4 P:mitotic sister chromatid segregation; F:protein binding; C:nucleus; C:chromosome, centromeric region    
contig00877 tetratricopeptide repeat domain 39a 443 20 5.03E-62 84.35% 1 F:nucleic acid binding    
contig00878 programmed cell death 5 1300 20 8.94E-49 91.45% 2 F:DNA binding; P:induction of apoptosis    
contig00879 fanconi complementation group l 625 20 2.17E-37 89.15% 8 C:cytoplasm; F:protein binding; P:zinc ion transport; P:ubiquitin cycle; F:ubiquitin-protein ligase activity; C:nucleus; F:zinc ion binding; P:DNA repair EC:6.3.2.19  
contig00880 ---NA--- 245 0     0      
contig00881 transducin -like 3 567 20 3.30E-81 80.40% 5 F:receptor signaling protein activity; C:small-subunit processome; P:G-protein signaling, coupled to cGMP nucleotide second messenger; P:rRNA processing; P:proteolysis    
contig00882 ---NA--- 433 0     0      
contig00883 tropomyosin 2 338 20 7.41E-26 83.90% 4 F:actin binding; C:muscle thin filament tropomyosin; F:structural constituent of cytoskeleton; P:muscle contraction    
contig00884 ---NA--- 259 0     0      
contig00885 synaptotagmin cytoplasmic rna interacting protein 474 20 1.90E-29 97.70% 8 C:microsome; P:RNA splicing; C:spliceosomal complex; F:protein binding; F:poly(A) RNA binding; P:mRNA processing; C:endoplasmic reticulum; F:nucleotide binding    
contig00886 ---NA--- 764 0     0      
contig00887 ---NA--- 263 0     0      
contig00888 telomerase reverse transcriptase 510 20 6.36E-66 67.40% 6 F:DNA binding; P:RNA-dependent DNA replication; F:RNA binding; F:telomeric template RNA reverse transcriptase activity; C:nucleus; C:intracellular organelle part    
contig00889 ---NA--- 547 0     0      
contig00890 ---NA--- 635 0     0      
contig00891 ---NA--- 437 0     0      
contig00892 testis-specific protein kinase 2 255 4 1.49E-13 64.25% 0      
contig00893 hexosaminidase (glycosyl hydrolase family catalytic domain) containing 604 20 6.82E-94 68.25% 2 F:cation binding; F:catalytic activity    
contig00894 glutamine-rich 1 287 20 8.10E-44 85.40% 2 F:protein binding; C:intracellular    
contig00895 acidic coiled-coil containing protein 3 2552 20 0 55.15% 1 F:protein binding    
contig00896 chromosome 9 open reading frame 64 321 20 2.58E-38 78.90% 2 F:F; C:C    
contig00897 mitogen-activated protein kinase 14 1171 20 5.70E-52 90.25% 20 P:angiogenesis; P:response to lipopolysaccharide; P:chondrocyte differentiation; P:skeletal muscle tissue development; F:protein C-terminus binding; F:MP kinase activity; P:protein amino acid autophosphorylation; P:embryonic cleavage; P:lipopolysaccharide-mediated signaling pathway; C:cytosolic part; P:DNA damage checkpoint; P:fatty acid oxidation; P:glucose metabolic process; P:positive regulation of erythrocyte differentiation; P:response to muramyl dipeptide; P:positive regulation of transcription from RNA polymerase II promoter; C:nucleus; F:ATP binding; C:spindle pole; P:stress-activated MAPK cascade    
contig00898 ---NA--- 268 0     0      
contig00899 mannosyl (alpha- -)-glycoprotein beta- -n-acetylglucosaminyltransferase 528 20 1.23E-94 90.70% 8 C:Golgi membrane; F:alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; F:sugar binding; C:membrane fraction; C:Golgi stack; P:oligosaccharide biosynthetic process; C:integral to membrane; P:protein amino acid N-linked glycosylation via asparagine EC:2.4.1.143  
contig00900 rna binding motif protein 28 344 20 4.61E-31 63.05% 1 F:binding    
100 Rows returned.
Go to records:
1-100, 101-200, 201-300, 301-400, 401-500, 501-600, 601-700, 701-800, 801-900, 901-1000, 1001-1100, 1101-1200, 1201-1300, 1301-1400, 1401-1500, 1501-1600, 1601-1700, 1701-1800, 1801-1900, 1901-2000, 2001-2100, 2101-2200, 2201-2300, 2301-2400, 2401-2500, 2501-2600, 2601-2700, 2701-2800, 2801-2900, 2901-3000, 3001-3100, 3101-3200, 3201-3300, 3301-3400, 3401-3500, 3501-3600, 3601-3700, 3701-3800, 3801-3900, 3901-4000, 4001-4100, 4101-4200, 4201-4300, 4301-4400, 4401-4500, 4501-4600, 4601-4700, 4701-4800, 4801-4900, 4901-5000, 5001-5100, 5101-5200, 5201-5300, 5301-5400, 5401-5500, 5501-5600, 5601-5700, 5701-5800, 5801-5900, 5901-6000, 6001-6100, 6101-6200, 6201-6300, 6301-6400, 6401-6500, 6501-6600, 6601-6700, 6701-6800, 6801-6900, 6901-7000, 7001-7100, 7101-7200, 7201-7300, 7301-7400, 7401-7500, 7501-7600, 7601-7700, 7701-7800, 7801-7900, 7901-8000, 8001-8100, 8101-8200, 8201-8300, 8301-8400, 8401-8500, 8501-8600, 8601-8700, 8701-8800, 8801-8900, 8901-9000, 9001-9100, 9101-9200, 9201-9300, 9301-9400, 9401-9500, 9501-9600, 9601-9700, 9701-9800, 9801-9900, 9901-10000, 10001-10100, 10101-10200, 10201-10300, 10301-10400, 10401-10500, 10501-10600, 10601-10700, 10701-10800, 10801-10900, 10901-11000, 11001-11100, 11101-11200, 11201-11208

Web Access Statistics © 2003-2025 NAGRP - Bioinformatics Coordination Program.
Contact: NAGRP Bioinformatics Team
Helpdesk